Literature DB >> 16898451

Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother.

Geraldine Mesoloras1, George A Sandison, Robert D Stewart, Jonathan B Farr, Wen C Hsi.   

Abstract

Scattered neutron dose equivalent to a representative point for a fetus is evaluated in an anthropomorphic phantom of the mother undergoing proton radiotherapy. The effect on scattered neutron dose equivalent to the fetus of changing the incident proton beam energy, aperture size, beam location, and air gap between the beam delivery snout and skin was studied for both a small field snout and a large field snout. Measurements of the fetus scattered neutron dose equivalent were made by placing a neutron bubble detector 10 cm below the umbilicus of an anthropomorphic Rando phantom enhanced by a wax bolus to simulate a second trimester pregnancy. The neutron dose equivalent in milliSieverts (mSv) per proton treatment Gray increased with incident proton energy and decreased with aperture size, distance of the fetus representative point from the field edge, and increasing air gap. Neutron dose equivalent to the fetus varied from 0.025 to 0.450 mSv per proton Gray for the small field snout and from 0.097 to 0.871 mSv per proton Gray for the large field snout. There is likely to be no excess risk to the fetus of severe mental retardation for a typical proton treatment of 80 Gray to the mother since the scattered neutron dose to the fetus of 69.7 mSv is well below the lower confidence limit for the threshold of 300 mGy observed for the occurrence of severe mental retardation in prenatally exposed Japanese atomic bomb survivors. However, based on the linear no threshold hypothesis, and this same typical treatment for the mother, the excess risk to the fetus of radiation induced cancer death in the first 10 years of life is 17.4 per 10,000 children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16898451     DOI: 10.1118/1.2207147

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  21 in total

1.  An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.

Authors:  Rui Zhang; Angélica Pérez-Andújar; Jonas D Fontenot; Phillip J Taddei; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Assessment of out-of-field absorbed dose and equivalent dose in proton fields.

Authors:  Ben Clasie; Andrew Wroe; Hanne Kooy; Nicolas Depauw; Jay Flanz; Harald Paganetti; Anatoly Rosenfeld
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

3.  Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking.

Authors:  J B Farr; A E Mascia; W C Hsi; C E Allgower; F Jesseph; A N Schreuder; M Wolanski; D F Nichiporov; V Anferov
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

4.  Range and modulation dependencies for proton beam dose per monitor unit calculations.

Authors:  Wen C Hsi; Andries N Schreuder; Michael F Moyers; Chris E Allgower; Jonathan B Farr; Anthony E Mascia
Journal:  Med Phys       Date:  2009-02       Impact factor: 4.071

5.  Energy spectrum control for modulated proton beams.

Authors:  Wen C Hsi; Michael F Moyers; Dmitri Nichiporov; Vladimir Anferov; Mark Wolanski; Chris E Allgower; Jonathan B Farr; Anthony E Mascia; Andries N Schreuder
Journal:  Med Phys       Date:  2009-06       Impact factor: 4.071

6.  Microdosimetric measurements for neutron-absorbed dose determination during proton therapy.

Authors:  Angélica Pérez-Andújar; Paul M Deluca; Allan F Thornton; Markus Fitzek; Draik Hecksel; Jonathan Farr
Journal:  Radiat Prot Dosimetry       Date:  2012-02-14       Impact factor: 0.972

Review 7.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

8.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

9.  Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault.

Authors:  Yuanshui Zheng; Wayne Newhauser; Eric Klein; Daniel Low
Journal:  Phys Med Biol       Date:  2009-11-04       Impact factor: 3.609

Review 10.  Is there a place for quantitative risk assessment?

Authors:  Eric J Hall
Journal:  J Radiol Prot       Date:  2009-05-19       Impact factor: 1.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.